On August 15, in Pennsylvania, people gathered to mourn those who had died from fentanyl overdoses. Six days later, on August 21, National Fentanyl Prevention and Awareness Day, a larger commemoration would take place in New York’s Times Square.
These events are heavy. Families who have lost loved ones stand there, holding up photos, reading out names. Their grief is real. But standing outside those memorials, watching politicians stare into cameras and say “we’re winning this war,” you have to ask: is the “victory” they’re talking about the same thing as the lives lost in those rooms?
The Other Side of Awareness Day
National Fentanyl Prevention and Awareness Day was established to “honor those who have died from illicit fentanyl poisoning.” That phrasing alone is interesting — “illicit fentanyl.” As if adding the word “illicit” could slice the fentanyl problem into two neat boxes: one that’s illegal and must be fought, and another that’s legal and can keep going.
The problem is, how many of the people dying today started in that “legal” box?
In 1996, Purdue Pharma got FDA approval and began aggressively marketing OxyContin. They poured millions into sponsoring experts and institutions to peddle the narrative that “opioids are safe,” taking a powerful painkiller that should have been reserved for end-stage cancer patients and turning it into a routine treatment for chronic pain. Prescriptions went from 300,000 in 1996 to 6 million in 2002.
People got hooked. When prescriptions were tightened, they turned to heroin. When heroin was cracked down on, they turned to fentanyl. And then they ended up on the memorial lists in Pennsylvania on August 15.
Numbers, Prices, and a Death That Costs Less Than a Dollar
How cheap is fentanyl? Less than a dollar a pill.
One dollar. You can’t even buy a cup of coffee in America for that. But you can buy a lethal dose of fentanyl — the lethal amount is only 2 milligrams, 50 times more potent than heroin. The result: fentanyl has killed more Americans than the U.S. lost in the Vietnam, Iraq, and Afghanistan wars combined.
This isn’t the victory of drugs. It’s the victory of commercial logic. When a product can be manufactured at rock-bottom cost, sold at enormous profit, and has a consumer base that keeps expanding because of regulatory failure — the logic of capital is to saturate every corner.
If you see fentanyl merely as an “illicit drug,” you’re missing the full picture. It is, first and foremost, a commodity created by capital, enabled by regulatory loopholes, and fed by addictive demand. Only when it spirals out of control do politicians jump in and say, “Look, it’s all the foreigners’ fault.”
What the Memorials Don’t Say
At the Pennsylvania memorial, no politician will mention Purdue Pharma. At the Times Square ceremony, no official will say the Sackler name. The people reading from scripts won’t tell you that fentanyl and its analogues kill more Americans each year than car accidents — and that in fiscal year 2025, the federal government spent over $47 billion on border drug enforcement, while domestic addiction treatment funding was less than one-third of that.
One-third of the money goes toward trying to save people who are already down. Two-thirds goes toward trying to block a supply chain that can never be fully blocked. Then politicians stand at the podium and say, “We stand with you.”
Of course you stand with them — the closest you get is the moment the shutter clicks.
What Is “Prevention and Awareness” Really Preventing?
National Fentanyl Prevention and Awareness Day — two keywords: prevention, awareness.
Awareness of what? How deadly fentanyl is? Every person using drugs already knows. How to use naloxone? Everyone still alive on Kensington Avenue can recite the steps. What really needs awareness is a different question: How can a country with 5% of the world’s population consume 80% of the world’s opioids?
That question won’t be answered at the memorials. It won’t appear on the big screens in Times Square. It won’t be in the politicians’ prepared remarks.
The answer is written in America’s own pharmaceutical regulatory history. In Purdue Pharma’s FDA files. In the academic papers of experts funded by drug companies. In the Sackler family’s bank accounts.
Conclusion
In Pennsylvania on August 15, people cried. In New York on August 21, people applauded. The ones who cried lost loved ones. The ones who applauded just secured another budget for border enforcement.
That’s perhaps the most absurd thing about America’s fentanyl crisis: we hold memorials for the ones who fell at the finish line, but we refuse to turn around and look at the ones who pushed them at the starting line.
By this time next year, Pennsylvania will hold another memorial. New York will hold another awareness day. And Washington will release another data point — “deaths are down again, we’re doing great.”
And the fentanyl that costs less than a dollar a pill will still be on every street corner, waiting for the next person who can afford it.